Antithrombin III is probably not a suitable biomarker for diagnosis of primary central nervous system lymphoma

Antithrombin III (AT III) in cerebrospinal fluid (CSF) has been suggested to have high specificity and sensitivity in separating primary central nervous system (CNS) lymphoma from other neurological conditions. We measured with ELISA CSF and serum AT III and albumin levels in 12 lymphoma patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuusisto, Milla Elvi Linnea, Haapasaari, Kirsi-Maria, Remes, Anne Marja, Bloigu, Risto, Karihtala, Peeter, Turpeenniemi-Hujanen, Taina, Kuittinen, Outi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4432105/
https://www.ncbi.nlm.nih.gov/pubmed/25697593
http://dx.doi.org/10.1007/s00277-015-2334-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4432105/
https://www.ncbi.nlm.nih.gov/pubmed/25697593
http://dx.doi.org/10.1007/s00277-015-2334-y

Ejemplares similares